2019
DOI: 10.1016/j.tibtech.2019.05.005
|View full text |Cite
|
Sign up to set email alerts
|

Policy Considerations Regarding Genome Editing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(16 citation statements)
references
References 2 publications
0
16
0
Order By: Relevance
“…The Organization for Economic Co-operation and Development (OECD) recognizes increasing impact of emerging new breeding technologies such as genome editing on global economies. For that reason, the OECD Conference on Genome Editing: Applications in Agriculture was held in June 2018 bringing together relevant stakeholders like scientific experts, decision makers, company representatives and others from more than 35 countries ( OECD Review of Fisheries: Policies and Summary Statistics 2017 , OECD, 2017 ; Friedrichs et al, 2019 ). Participants discussed that regulatory approaches for genome editing should be determined to achieve policy objectives considering both, precaution and innovation through better communication between all stakeholders ( Friedrichs et al, 2019 ).…”
Section: Developments In Global Organizationsmentioning
confidence: 99%
See 1 more Smart Citation
“…The Organization for Economic Co-operation and Development (OECD) recognizes increasing impact of emerging new breeding technologies such as genome editing on global economies. For that reason, the OECD Conference on Genome Editing: Applications in Agriculture was held in June 2018 bringing together relevant stakeholders like scientific experts, decision makers, company representatives and others from more than 35 countries ( OECD Review of Fisheries: Policies and Summary Statistics 2017 , OECD, 2017 ; Friedrichs et al, 2019 ). Participants discussed that regulatory approaches for genome editing should be determined to achieve policy objectives considering both, precaution and innovation through better communication between all stakeholders ( Friedrichs et al, 2019 ).…”
Section: Developments In Global Organizationsmentioning
confidence: 99%
“…Furthermore, it is important that the different legal systems understand their respective regulatory and policy approaches to genome editing. To minimize difficulties arising through different regulatory approaches a common understanding is obligatory ( Friedrichs et al, 2019 ).…”
Section: Developments In Global Organizationsmentioning
confidence: 99%
“…Some of these questions are currently a matter of lively discussions in the synthetic biology arena, such as the role of evolution in the performance of synthetic organisms or how (and if) a bioprocess based on such organisms could be scaled up [11]. These emerging approaches will also shine a new light on safety assessment and regulation of genome-edited products [12], since the properties of whole-cell catalysts (including those that should be avoided) will be rendered amenable to tailoring. One way or the other, the work by Fredens and colleagues constitutes a formidable stepping stone toward the understanding and (re)programming of the core properties of the cellthe consequences of which will start to become evident in the near future, particularly in the domain of bioproduction.…”
Section: Synthesis Of Recoded Bacterial Genomes Toward Bespoke Biocatmentioning
confidence: 99%
“…Proponents consider the procedures to be faster, more precise, more effective, and thus significantly less expensive than classical genetic engineering techniques, and the hope has been expressed that this might make them more accessible for use by small and medium-sized enterprises. At the same time, NBTs have given rise to a number of concerns, e.g., regarding risks associated with side effects and off-target effects, as well as the possibility of negative socio-economic impacts, and there is an ongoing debate about responsible regulation [17][18][19][20][21][22]. Possible conflicts of interest in research and regulation are also an issue, for example, when research is publicly funded [23,24].…”
Section: Introductionmentioning
confidence: 99%
“…Fourteen EU member states have called for a "unified approach" on the EU level [28] that could lead to a more liberal approach, exempting some NBTs from GMO regulation. Also unclear is how the ruling could be applied to imported goods, as NBTs are already in use in some countries, such as the USA, where some products and product groups produced using NBTs cannot be distinguished using currently available technologies from those of conventional agriculture [21]. On 8 November 2019, the European Commission was requested by the EU member states to study "the status of novel genomic techniques under Union law" [29].…”
Section: Introductionmentioning
confidence: 99%